Oct 1, 2020
This is an exciting moment in the management of a devastating neurologic condition -- Huntington's Disease. As we know, this genetic disease often hits patients at the prime of life and, because it is autosomal dominant, can be haunting for affected families. As we'll discuss today, new developments in biomarkers and therapies for Huntington's are converging into a more hopeful picture for those affected. In this episode, we’ll hear from two Huntington Disease experts -- Dr. Jee Bang, Clinical Director of Johns Hopkins Huntington Disease Center of Excellence and Assistant Professor of Neurology... and ANA investigates producer Dr. Danny Bega, Director of the Northwestern Medicine Huntington Disease Center of Excellence and Associate Professor of Neurology.